Gene · 1500
Papers4,443
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,443
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of TMX2-CTNND1 polymorphism on cortical thickness in schizophrenia patients and unaffected siblings: an exploratory study based on target region sequencing. | Braz J Psychiatry | 2024 | 38219215 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
| Corrigendum: Role of glutamine in the mediation of E-cadherin, p120-catenin and inflammation in ventilator-induced lung injury. | Chin Med J (Engl) | 2024 | 38214297 | PubTator, text mining | PubMed |
| ZO-1 regulates the migration of mesenchymal stem cells in cooperation with α-catenin in response to breast tumor cells. | Cell Death Discov | 2024 | 38212369 | PubTator, text mining | PubMed |
| CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases. | Heliyon | 2024 | 38187312 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| Anoikis-related CTNND1 is associated with immuno-suppressive tumor microenvironment and predicts unfavorable immunotherapeutic outcome in non-small cell lung cancer. | J Cancer | 2024 | 38169514 | PubTator, text mining | PubMed |
| Endolysosomal TRPML1 channel regulates cancer cell migration by altering intracellular trafficking of E-cadherin and β1-integrin. | J Biol Chem | 2024 | 38141765 | PubTator, text mining | PubMed |
| Deciphering the emerging landscape of HOX genes in cardiovascular biology, atherosclerosis and beyond (Review). | Int J Mol Med | 2024 | 38131178 | PubTator, text mining | PubMed |
| Dynamic tuft cell expansion during gastric metaplasia and dysplasia. | J Pathol Clin Res | 2024 | 38117182 | PubTator, text mining | PubMed |
| Prioritizing de novo potential non-canonical splicing variants in neurodevelopmental disorders. | EBioMedicine | 2024 | 38113761 | PubTator, text mining | PubMed |
| Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments. | J Ethnopharmacol | 2024 | 38042385 | PubTator, text mining | PubMed |
| DRMref: comprehensive reference map of drug resistance mechanisms in human cancer. | Nucleic Acids Res | 2024 | 37986230 | PubTator, text mining | PubMed |
| Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression. | Adv Sci (Weinh) | 2024 | 37985644 | PubTator, text mining | PubMed |
| A computational study for understanding the impact of p120-catenin on the cis-dimerization of cadherin. | J Mol Cell Biol | 2024 | 37757467 | PubTator, text mining | PubMed |
| Oncogenic MORC2 in cancer development and beyond. | Genes Dis | 2024 | 37692502 | PubTator, text mining | PubMed |
| Damaging Mutations in AFDN Contribute to Risk of Nonsyndromic Cleft Lip With or Without Cleft Palate. | Cleft Palate Craniofac J | 2024 | 36384317 | PubTator, text mining | PubMed |
| Deep learning-based immunohistochemical estimation of breast cancer via ultrasound image applications. | Front Oncol | 2023 | 38264739 | PubTator, text mining | PubMed |
| Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction. | JACC Basic Transl Sci | 2023 | 38205347 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. | Int J Mol Sci | 2023 | 38203503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1500/papers?page=9